Clinical Trials Logo
  1. Home
  2. Chemoradiotherapy
  3. NCT05129774

Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM

Chemoradiotherapy Clinical Trial

Official title:
Concurrent Chemoradiotherapy Sequenced Radical Surgery for Para-aortic Lymph Node Metastasis of Left-sided Colon and Rectal Cancer

Clinical Trial Summary

In left-sided colon and rectal cancer, the occurrence of synchronous para-aortic lymph node metastasis is rare, with the incidence of being approximate 1-2%. Currently, there has been no standard treatment strategy for this situation. The present trial is designed to evaluate the safety and efficacy of para-aortic lymph node dissection for left-sided colon and rectal cancer with synchronous para-aortic lymph node metastasis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05129774
Study type Interventional
Source Qilu Hospital of Shandong University
Contact Yong Dai, M.D. Ph.D.
Phone +8618560085117
Email yongdai@hotmail.com
Status Not yet recruiting
Phase N/A
Start date January 1, 2022
Completion date January 1, 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05161572 - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Phase 2
Completed NCT02399306 - Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma Phase 3
Recruiting NCT03286348 - Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer N/A
Recruiting NCT04821765 - Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer Phase 2
Recruiting NCT04278287 - Chemoradiotherapy in Unresectable Esophageal Cancer Phase 1/Phase 2
Recruiting NCT05863260 - Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer
Active, not recruiting NCT05027165 - Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
Completed NCT04207918 - A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer Phase 2
Recruiting NCT06219083 - Nutrition and Cancer Outcomes in Shaanxi Chemoradiotherapy
Active, not recruiting NCT04764227 - Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) Phase 2
Recruiting NCT06421376 - Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer Phase 2
Recruiting NCT05311566 - PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer Phase 2
Not yet recruiting NCT05286086 - Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative N/A
Recruiting NCT04772001 - Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer N/A
Recruiting NCT06429839 - Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients Phase 2
Recruiting NCT06410651 - Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma Phase 2
Recruiting NCT03177382 - Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors Phase 3
Not yet recruiting NCT06413342 - Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma Phase 2
Completed NCT05590650 - A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients Phase 1
Recruiting NCT00973778 - A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma Phase 2